Philip Scheltens

PROF.DR., (Principal Investigator)

20002020
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2020

Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An 123I-FP-CIT SPECT study

van der Zande, J. J., Joling, M., Happach, I. G., Vriend, C., Scheltens, P., Booij, J. & Lemstra, A. W., 2020, In : NeuroImage: Clinical. 25, 102062.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal

Alzheimer's Disease Neuroimaging Initiative, 2019, In : Neurology. 92, 23, p. e2699-e2705

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Activities 2017 2019

  • 2 Invited talk
  • 1 Membership of board

The future of Alzheimer Diagnosis: the basis for therapy

Philip Scheltens (Speaker)
9 Nov 2019

Activity: Talk or presentationInvited talk

Amyloid PET daily practice experience in the Netherlands

Philip Scheltens (Speaker)
26 Oct 2019

Activity: Talk or presentationInvited talk

Translational Neuroscience Network Conference 2017 (Event)

Jeroen Hoozemans (Chair), MM Schoonheim (Chair), MMM Wilhelmus (Chair), P Scheltens (Chair), AB Brussaard (Chair)
12 Oct 2017

Activity: MembershipMembership of board